(Q30230004)

11 June 2017

title

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza (English)

1 reference

11 June 2017

1 reference

1 reference

2

Terrence M Tumpey

1 reference

11 June 2017

4

Jessica A Belser

1 reference

11 June 2017

9

Rick A Bright

1 reference

11 June 2017

1

Peter Pushko

1 reference

11 June 2017

7

Gale Smith

1 reference

11 June 2017

Neal Van Hoeven

3

1 reference

11 June 2017

Robin Robinson

series ordinal

5

1 reference

11 June 2017

Margret Nathan

series ordinal

6

1 reference

11 June 2017

D Craig Wright

series ordinal

8

1 reference

11 June 2017

language of work or name

English

0 references

publication date

9 March 2007

1 reference

11 June 2017

1 reference

11 June 2017

volume

25

1 reference

11 June 2017

issue

21

1 reference

11 June 2017

page(s)

4283-4290

1 reference

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Pandemic Threat Posed by Avian Influenza A Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Confronting the avian influenza threat: vaccine development for a potential pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Predictability and preparedness in influenza control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Are we ready for pandemic influenza?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Human infection with influenza H9N2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Continuing evolution of H9N2 influenza viruses in Southeastern China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Particulate delivery systems for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Immunity to influenza A H9N2 viruses induced by infection and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

New adjuvants for parenteral and mucosal vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Adhesion-mediated enhancement of the adjuvant activity of alum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Recombinant neuraminidase vaccine protects against lethal influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/K(b) transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.02.059

1 reference

11 June 2017

1 reference